CUP AND HANDLE FORMING NEW PT 6.50+Price above 200 EMA. Bounced off-diagonal support. Bounced off 50% retracement. RSI Oversold. Confirmed trend reversal.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.50 USD
−130.64 M USD
10.00 M USD
45.62 M
About Verastem, Inc.
Sector
Industry
CEO
Daniel W. Paterson
Website
Headquarters
Needham
Founded
2010
FIGI
BBG00JVRMLS3
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
OVERSOLD, BOUNCED OFF TREND LINE, TESTED 50% RETRACEMENTOVERSOLD, BOUNCED OFF TREND LINE, TESTED 50% RETRACEMENT. Great price to buy in my opinion.
FDA gave breakthrough designation..Verastem announced it received FDA Breakthrough Therapy designation for VS-6766 with defactinib in recurrent low-grade serous ovarian cancer.
If the flag holds, it looks like it could hit around $4.60. Considering adding to my position today. But probably will just hold with what I have.
VSTM Verastem Inc. - Is VSTM forming a W on a weekly chart?Is VSTM forming a W on a weekly chart?
Decide for yourself.
Resistance @2,7 @4,7 @10,30 and the sky is above 19 $
Good luck and happy trading everyone!
VSTM Verastem - nice W forming - is this going to the sky soon? VSTM - nice W forming - is this going to the sky @ 19 $ and above ?
Nice volume and start of steady uptrend.
GOOD LUCK and enjoy investing
Target in sight. $vstmLooks to me like an ascending triangle breakout. Unfortunately, the volume is fairly week, but we'll see where it takes us.
I plan on taking profits in the yellow area. I might run a trailing stop loss when it enters that area and just let it run.
$vstm
$VSTM Verastem, Inc., Potential 20% UpsideVerastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA™ (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibit
$VSTM Bullish opportunity targeting double current price 1.48Bullish setup formed by 3 red daily candles closing at same price . this pattern can lead to significant price change and RSI signal positively .. bullish long more likely with stoploss at 1.25 (not far away) risk reward (-20% vs +100%). to be watched closely!!
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 0LOV is 4.46 USD — it has decreased by −7.35% in the past 24 hours. Watch VERASTEM INC COM USD0.0001 (POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange VERASTEM INC COM USD0.0001 (POST REV SPLIT) stocks are traded under the ticker 0LOV.
0LOV stock has fallen by −19.57% compared to the previous week, the month change is a −38.40% fall, over the last year VERASTEM INC COM USD0.0001 (POST REV SPLIT) has showed a −60.23% decrease.
We've gathered analysts' opinions on VERASTEM INC COM USD0.0001 (POST REV SPLIT) future price: according to them, 0LOV price has a max estimate of 20.00 USD and a min estimate of 8.00 USD. Watch 0LOV chart and read a more detailed VERASTEM INC COM USD0.0001 (POST REV SPLIT) stock forecast: see what analysts think of VERASTEM INC COM USD0.0001 (POST REV SPLIT) and suggest that you do with its stocks.
0LOV reached its all-time high on Oct 5, 2018 with the price of 85.92 USD, and its all-time low was 2.14 USD and was reached on Aug 5, 2024. View more price dynamics on 0LOV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0LOV stock is 7.94% volatile and has beta coefficient of 0.75. Track VERASTEM INC COM USD0.0001 (POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is VERASTEM INC COM USD0.0001 (POST REV SPLIT) there?
Today VERASTEM INC COM USD0.0001 (POST REV SPLIT) has the market capitalization of 247.67 M, it has decreased by −7.37% over the last week.
Yes, you can track VERASTEM INC COM USD0.0001 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
VERASTEM INC COM USD0.0001 (POST REV SPLIT) is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
0LOV earnings for the last quarter are −1.33 USD per share, whereas the estimation was −0.83 USD resulting in a −60.48% surprise. The estimated earnings for the next quarter are −0.67 USD per share. See more details about VERASTEM INC COM USD0.0001 (POST REV SPLIT) earnings.
VERASTEM INC COM USD0.0001 (POST REV SPLIT) revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 200.00 K USD. In the next quarter, revenue is expected to reach 0.00 USD.
0LOV net income for the last quarter is −64.55 M USD, while the quarter before that showed −23.97 M USD of net income which accounts for −169.33% change. Track more VERASTEM INC COM USD0.0001 (POST REV SPLIT) financial stats to get the full picture.
No, 0LOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 16, 2025, the company has 78 employees. See our rating of the largest employees — is VERASTEM INC COM USD0.0001 (POST REV SPLIT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VERASTEM INC COM USD0.0001 (POST REV SPLIT) EBITDA is −114.93 M USD, and current EBITDA margin is −1.15 K%. See more stats in VERASTEM INC COM USD0.0001 (POST REV SPLIT) financial statements.
Like other stocks, 0LOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VERASTEM INC COM USD0.0001 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VERASTEM INC COM USD0.0001 (POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VERASTEM INC COM USD0.0001 (POST REV SPLIT) stock shows the sell signal. See more of VERASTEM INC COM USD0.0001 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.